[HTML][HTML] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - BMC infectious …, 2021 - Springer
Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

[PDF][PDF] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - 2021 - scholar.archive.org
Background and objectives: An effective treatment option is not yet available for SARS-
CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more …

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.

N OkumuÅ, NÅ Demirtürk, RA Çetinkaya… - BMC Infectious …, 2021 - go.gale.com
Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

[PDF][PDF] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - 2021 - binasss.sa.cr
Background and objectives: An effective treatment option is not yet available for SARS-
CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more …

[HTML][HTML] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya… - BMC Infectious …, 2021 - ncbi.nlm.nih.gov
Materials and methods Patients with severe COVID19 pneumonia were included in the
study, which was planned as a prospective, randomized, controlled, single-blind phase 3 …

[HTML][HTML] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk… - BMC Infectious …, 2021 - bmcinfectdis.biomedcentral.com
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-
19 pandemic and whose effects are felt more and more every day. Ivermectin is among the …

[HTML][HTML] Evaluation of the Effectiveness and Safety of Adding Ivermectin to Treatment in Severe COVID-19 Patients

N Okumuş, N Demirtürk, Ç RA, R GÜNER, İY Avcı… - 2021 - europepmc.org
BACKGROUND AND OBJECTIVES: An effective treatment option is not yet available for
SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and …

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya… - BMC Infectious …, 2021 - search.proquest.com
Materials and methods Patients with severe COVID19 pneumonia were included in the
study, which was planned as a prospective, randomized, controlled, single-blind phase 3 …

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk… - BMC infectious …, 2021 - pubmed.ncbi.nlm.nih.gov
Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

[PDF][PDF] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

N Okumuş, N Demirtürk, RA Çetinkaya, R Güner… - 2021 - academia.edu
Background and objectives: An effective treatment option is not yet available for SARS-
CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more …